Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2024 / Apr / To Screen, or not to Screen?
Hematology Screening and monitoring Hematology Insights

To Screen, or not to Screen?

How would you respond to the pediatric diabetes screening debate?

By Helen Bristow 04/09/2024 Discussion 1 min read

Share

Just because we can do something that will improve health outcomes – does that mean we should do it? I ask because a recent article in Science (1) raised an interesting question: should all children be screened for type 1 diabetes? After all, blood tests are available that can predict the onset of the disease years in advance. And tepilizumab, which can delay the onset of the condition, is now available in the USA. So why not simply screen all children and keep those at risk healthier for longer?

Well, mental health experts might object to a mass screening program to spare youngsters from health anxiety – itself a detrimental condition (2). Reports suggest that health anxiety amongst children has increased since the COVID-19 pandemic (3), when screening for infection became commonplace. Many of us may have observed young family members obsessively washing hands or repeatedly questioning their chances of survival during that time. Could screening children for diabetes cause them to grow up with a gnawing fear of developing a dreadful, incurable illness? Might it lead to years of hypervigilance, self-monitoring, detrimental Googling, and overuse of medical care?

Pandemic aside, health screening is somewhat alien to most children. They might be tested for a range of conditions before and immediately after they are born, and then offered no further tests until middle or old age. And though inoculations – which kids are more likely to experience – undoubtedly raise their awareness of deadly diseases, they also allay the fears of contracting them. Screening, it could be argued, might do the opposite.

Economists may also have concerns about such a scheme. Less than one percent of children are likely to test positive for diabetes biomarkers; health authorities might find it difficult to justify the huge bill for mass screening versus potential savings to the costs of treating adolescents with diabetes.

Might there be a compromise that addresses both of the above-mentioned barriers? Perhaps families should decide whether their children should be screened? 

In any case, questions like those raised here are guaranteed to divide opinions – and The Pathologist team is always interested to hear yours. Join the debate by dropping us an email: edit@thepathologist.com.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. Science (2024). Available at: https://www.science.org/content/article/should-doctors-screen-all-kids-type-1-diabetes
  2. A Haig-Ferguson et al, Behav Cogn Psychother, 49, 2 (2021). PMID: 32829718.
  3. C U Rask et al, J Child Psycol Psychiatry, 65, 4 (2024). PMID: 37909255.

About the Author(s)

Helen Bristow

Combining my dual backgrounds in science and communications to bring you compelling content in your speciality.

More Articles by Helen Bristow

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Flexible Solutions With FlexVUE
Screening and monitoring
Flexible Solutions With FlexVUE

December 29, 2021

1 min read

Quickly customize your immune panels with Ultivue’s new innovation

What’s New in Infectious Disease? (December 2021)
Screening and monitoring
What’s New in Infectious Disease?

December 23, 2021

1 min read

The latest research and news on COVID-19 and the infectious disease landscape

A Pig In a Poke
Screening and monitoring
A Pig In a Poke

October 21, 2016

1 min read

When importing livestock for food or breeding, European countries may inadvertently open their borders to superbugs as well

Sneaky Superbugs
Screening and monitoring
Sneaky Superbugs

October 21, 2016

1 min read

Norway’s strict LA-MRSA transmission measures prevent the import of almost all live pigs – but the bacteria have found a new way in

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.